
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The biogenesis, function and clinical significance of circular RNAs in breast cancer
Yan Zeng, Yutian Zou, Guanfeng Gao, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 38
Yan Zeng, Yutian Zou, Guanfeng Gao, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
Circular RNA: A promising new star of vaccine
Jindong Xie, F. Ye, Xinpei Deng, et al.
Journal of Translational Internal Medicine (2023) Vol. 11, Iss. 4, pp. 372-381
Open Access | Times Cited: 45
Jindong Xie, F. Ye, Xinpei Deng, et al.
Journal of Translational Internal Medicine (2023) Vol. 11, Iss. 4, pp. 372-381
Open Access | Times Cited: 45
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Circular RNAs: New layer of complexity evading breast cancer heterogeneity
Alyaa Dawoud, Z Zakaria, Hannah Hisham Rashwan, et al.
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 60-74
Open Access | Times Cited: 41
Alyaa Dawoud, Z Zakaria, Hannah Hisham Rashwan, et al.
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 60-74
Open Access | Times Cited: 41
circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis
Zhigang Zhou, Jing Qin, Cailu Song, et al.
Journal of Cancer (2023) Vol. 14, Iss. 13, pp. 2574-2584
Open Access | Times Cited: 39
Zhigang Zhou, Jing Qin, Cailu Song, et al.
Journal of Cancer (2023) Vol. 14, Iss. 13, pp. 2574-2584
Open Access | Times Cited: 39
Circular RNAs: Emerging roles and new insights in human cancers
Zhilin He, Qubo Zhu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115217-115217
Open Access | Times Cited: 34
Zhilin He, Qubo Zhu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115217-115217
Open Access | Times Cited: 34
Circular RNAs in the KRAS pathway: Emerging players in cancer progression
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Advanced approaches of the use of circRNAs as a replacement for cancer therapy
Goran Sedeeq Hama Faraj, Bashdar Mahmud Hussen, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 811-830
Open Access | Times Cited: 10
Goran Sedeeq Hama Faraj, Bashdar Mahmud Hussen, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 811-830
Open Access | Times Cited: 10
Interactions between circRNA and protein in breast cancer
Bin Yang, Ya‐Wen Wang, Kai Zhang
Gene (2023) Vol. 895, pp. 148019-148019
Closed Access | Times Cited: 18
Bin Yang, Ya‐Wen Wang, Kai Zhang
Gene (2023) Vol. 895, pp. 148019-148019
Closed Access | Times Cited: 18
Circular RNAs: implications of signaling pathways and bioinformatics in human cancer
Fan Hu, Yin Peng, Xinmin Fan, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 2, pp. 104-128
Open Access | Times Cited: 15
Fan Hu, Yin Peng, Xinmin Fan, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 2, pp. 104-128
Open Access | Times Cited: 15
FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis
Xiaojia Huang, Jinna Wu, Yizhuo Wang, et al.
Experimental Cell Research (2023) Vol. 431, Iss. 1, pp. 113737-113737
Closed Access | Times Cited: 14
Xiaojia Huang, Jinna Wu, Yizhuo Wang, et al.
Experimental Cell Research (2023) Vol. 431, Iss. 1, pp. 113737-113737
Closed Access | Times Cited: 14
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis
Xiang Song, Xinzhao Wang, Xiqi Chen, et al.
Journal of Proteomics (2023) Vol. 292, pp. 105055-105055
Closed Access | Times Cited: 14
Xiang Song, Xinzhao Wang, Xiqi Chen, et al.
Journal of Proteomics (2023) Vol. 292, pp. 105055-105055
Closed Access | Times Cited: 14
CircRNA circRREB1 promotes tumorigenesis and progression of breast cancer by activating Erk1/2 signaling through interacting with GNB4
Hong Chen, Xiaosong Wang, Hang Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28785-e28785
Open Access | Times Cited: 5
Hong Chen, Xiaosong Wang, Hang Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28785-e28785
Open Access | Times Cited: 5
CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis
Jiulong Ma, Chen Chen, Zhimin Fan, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125295-125295
Closed Access | Times Cited: 13
Jiulong Ma, Chen Chen, Zhimin Fan, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125295-125295
Closed Access | Times Cited: 13
Circular RNAs: key players in tumor immune evasion
Mahla Sanati, Soudeh Ghafouri‐Fard
Molecular and Cellular Biochemistry (2025)
Closed Access
Mahla Sanati, Soudeh Ghafouri‐Fard
Molecular and Cellular Biochemistry (2025)
Closed Access
Molecular Mechanisms of circKIF4A in Breast Cancer Progression
Haoyong Liu, Lingdiao Zeng, Hualin Chen, et al.
Asia-Pacific Journal of Clinical Oncology (2025)
Closed Access
Haoyong Liu, Lingdiao Zeng, Hualin Chen, et al.
Asia-Pacific Journal of Clinical Oncology (2025)
Closed Access
CircMRP4 orchestrates podocytes injury via the miR-499-5p/RRAGB/mTORC1 axis in diabetic kidney disease
Shujun Deng, Lingzhi Huang, Yawen Shao, et al.
Cellular Signalling (2025) Vol. 127, pp. 111611-111611
Closed Access
Shujun Deng, Lingzhi Huang, Yawen Shao, et al.
Cellular Signalling (2025) Vol. 127, pp. 111611-111611
Closed Access
Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple negative breast cancer
Yi Xie, Jindong Xie, Guoxian Huang, et al.
Cancer Letters (2025), pp. 217734-217734
Closed Access
Yi Xie, Jindong Xie, Guoxian Huang, et al.
Cancer Letters (2025), pp. 217734-217734
Closed Access
Identification of biomarkers of male infertility through the circRNA expression profiling of seminal plasma
Zhaode Liu, Xinrui Li, Xiaoyu Yang, et al.
Journal of Biomedical Research (2025) Vol. 39, pp. 1-1
Open Access
Zhaode Liu, Xinrui Li, Xiaoyu Yang, et al.
Journal of Biomedical Research (2025) Vol. 39, pp. 1-1
Open Access
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications
Saurabh Dey, Bini Biswas, Angela Manoj Appadan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3752-3752
Open Access | Times Cited: 9
Saurabh Dey, Bini Biswas, Angela Manoj Appadan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3752-3752
Open Access | Times Cited: 9
The therapeutic potential of circular RNA in triple-negative breast cancer
Aiqi Xu, Lewei Zhu, Chengcai Yao, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Aiqi Xu, Lewei Zhu, Chengcai Yao, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Circ‐ADAM9 Knockdown Reduces Insulin Resistance and Placental Injury in Diabetic Mice via MAPK Pathway Inactivation
Ai Zhao, Yawen Yang, Yijun Yang, et al.
American Journal of Reproductive Immunology (2024) Vol. 92, Iss. 5
Closed Access | Times Cited: 2
Ai Zhao, Yawen Yang, Yijun Yang, et al.
American Journal of Reproductive Immunology (2024) Vol. 92, Iss. 5
Closed Access | Times Cited: 2
CICADA: a circRNA effort toward the ghost proteome
Liyuan Fan, Xinyuan Zhou, Mian Li, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 2
Liyuan Fan, Xinyuan Zhou, Mian Li, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 2
Junwen Luo, Zhongxian Tian, Yongjia Zhou, et al.
Cancer Science (2023) Vol. 114, Iss. 7, pp. 2835-2847
Open Access | Times Cited: 6
CircANKRD17 promotes glycolysis by inhibiting miR‐143 in breast cancer cells
Hong Chen, Lingfei Zhang, Lu Zhang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 12, pp. 2765-2777
Closed Access | Times Cited: 6
Hong Chen, Lingfei Zhang, Lu Zhang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 12, pp. 2765-2777
Closed Access | Times Cited: 6